Japanese Pharmacokinetic Bridging Study for CC-93538
NCT04096105
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
48
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Volunteers
Interventions
DRUG:
CC-93538
Sponsor
Celgene